(19)
(11) EP 2 552 933 A1

(12)

(43) Date of publication:
06.02.2013 Bulletin 2013/06

(21) Application number: 11714467.5

(22) Date of filing: 31.03.2011
(51) International Patent Classification (IPC): 
C07H 19/20(2006.01)
A61P 31/14(2006.01)
A61K 31/7076(2006.01)
(86) International application number:
PCT/US2011/030767
(87) International publication number:
WO 2011/123672 (06.10.2011 Gazette 2011/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 31.03.2010 US 319548 P
17.06.2010 US 355940 P

(71) Applicant: Gilead Pharmasset LLC
Foster City, CA 94404 (US)

(72) Inventors:
  • CHANG, Wonsuk
    Princeton NJ 08540 (KP)
  • NADUTHAMBI, Devan
    Plainsboro, NJ 08536 (US)
  • NAGARATHNAM, Dhanapalan
    Bethany, CT 06524 (US)
  • PAMULAPATI, Ganapati, Reddy
    Plainsboro, NJ 08536 (US)
  • ROSS, Bruce, S.
    Plainaboro, NJ 08536 (US)
  • SOFIA, Michael, Joseph
    Doylestown, PA 18901 (US)
  • ZHANG, Hai-Ren
    Ellicott City, MD 21043 (US)

(74) Representative: Schwarz & Partner 
Patentanwälte Wipplingerstraße 30
1010 Wien
1010 Wien (AT)

   


(54) PURINE NUCLEOSIDE PHOSPHORAMIDATE